RS

Rajasweta Samal

Active Director Director DIN 09732251
DIN 09732251 First appointment Sep 2022 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajasweta Samal

Data last updated:

Rajasweta Samal is a Director at Everiva Pharmaceuticals Private Limited (since 2022). The company operates in Trading.

DIN 09732251
Primary Designation Director
Industry Trading
First Appointment 09 Sep 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Sep 20222022Active

Board colleagues of Rajasweta Samal

NameDINCompanyDesignation
Rakesh Swain09732252Everiva Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Everiva Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rajasweta Samal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajasweta Samal

Rajasweta Samal currently holds 1 directorship: Everiva Pharmaceuticals Private Limited (Director, since 09 Sep 2022).

Rajasweta Samal was first appointed on 09 Sep 2022 as Director at Everiva Pharmaceuticals Private Limited.

The current boards of Rajasweta Samal's companies include Rakesh Swain (Everiva Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available